– Phase 1b study results were published simultaneously in Nature Medicine and presented at the Society for Immunotherapy of Cancer 2024 – – Encouraging data adds to the body of evidence supporting ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback